| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5815493 | Neuropharmacology | 2012 | 15 Pages |
Abstract
⺠Pathophysiology of depression is associated with dysfunction of glutamatergic system. ⺠Drugs targeting glutamate system may have rapid and sustained antidepressant effects. ⺠A paradigm shift from monoamine to glutamate may bring new impulse to the field.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Gerard Sanacora, Giulia Treccani, Maurizio Popoli,